Hollencrest Capital Management Pfizer Inc Transaction History

Hollencrest Capital Management

$2.23 Billion
Q2 2024

A detailed history of Hollencrest Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Hollencrest Capital Management holds 1,933 shares of PFE stock, worth $57,332. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,933

Previous 1,910 1.2%

Holding current value

$57,332

Previous $53,000 1.89%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $580 - $680	23 Added 1.2%	1,933 $54,000
Q1 2024 May 01, 2024	SELL	$25.89 - $29.73 $230,654 - $264,864	-8,909 Reduced 82.35%	1,910 $53,000
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $26 - $33	1 Added 0.01%	10,819 $311,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $6,450 - $7,539	-201 Reduced 1.82%	10,818 $358,000
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $16,651 - $19,265	-461 Reduced 4.02%	11,019 $404,000
Q1 2023 May 16, 2023	BUY	$39.39 - $51.28 $317,601 - $413,470	8,063 Added 235.97%	11,480 $468,000
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $142,659 - $186,226	3,417 New	3,417 $175,000
Q2 2022 Jul 21, 2022	BUY	$46.53 - $55.17 $19,356 - $22,950	416 Added 7.22%	6,178 $324,000
Q1 2022 Apr 18, 2022	BUY	$45.75 - $56.69 $7,045 - $8,730	154 Added 2.75%	5,762 $298,000
Q4 2021 Jan 07, 2022	BUY	$41.32 - $61.25 $6,445 - $9,555	156 Added 2.86%	5,608 $331,000
Q3 2021 Oct 13, 2021	SELL	$39.25 - $50.42 $52,555 - $67,512	-1,339 Reduced 19.72%	5,452 $234,000
Q2 2021 Jul 21, 2021	SELL	$35.91 - $40.68 $1.94 Million - $2.2 Million	-54,038 Reduced 88.84%	6,791 $266,000
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $418,691 - $472,200	-12,502 Reduced 17.05%	60,829 $2.2 Million
Q4 2020 Jan 26, 2021	BUY	$33.47 - $42.56 $35,076 - $44,602	1,048 Added 1.45%	73,331 $2.7 Million
Q3 2020 Oct 13, 2020	SELL	$31.75 - $37.25 $15,684 - $18,401	-494 Reduced 0.68%	72,283 $2.65 Million
Q2 2020 Jul 16, 2020	BUY	$30.12 - $36.54 $49,637 - $60,217	1,648 Added 2.32%	72,777 $2.38 Million
Q1 2020 May 01, 2020	SELL	$27.03 - $38.62 $317,926 - $454,248	-11,762 Reduced 14.19%	71,129 $2.32 Million
Q4 2019 Jan 23, 2020	SELL	$32.92 - $37.36 $258,323 - $293,163	-7,847 Reduced 8.65%	82,891 $3.25 Million
Q3 2019 Oct 23, 2019	SELL	$32.49 - $42.13 $101,466 - $131,571	-3,123 Reduced 3.33%	90,738 $3.26 Million
Q2 2019 Jul 18, 2019	SELL	$36.98 - $41.52 $418,169 - $469,508	-11,308 Reduced 10.75%	93,861 $4.07 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $9,412 - $10,341	-251 Reduced 0.24%	105,169 $4.47 Million
Q1 2019 Apr 04, 2019	BUY	$37.5 - $41.2 $9,412 - $10,341	251 Added 0.24%	105,420 $4.48 Million
Q4 2018 May 09, 2019	SELL	$38.47 - $43.86 $9,655 - $11,008	-251 Reduced 0.24%	105,523 $4.61 Million
Q4 2018 May 09, 2019	SELL	$38.47 - $43.86 $13,618 - $15,526	-354 Reduced 0.34%	105,169 $4.36 Million
Q4 2018 Jan 03, 2019	BUY	$38.47 - $43.86 $23,274 - $26,535	605 Added 0.58%	105,774 $4.62 Million
Q3 2018 May 09, 2019	SELL	$34.47 - $41.81 $41,019 - $49,753	-1,190 Reduced 1.12%	105,169 $4.47 Million
Q3 2018 Oct 04, 2018	BUY	$34.47 - $41.81 $57,461 - $69,697	1,667 Added 1.59%	106,359 $4.69 Million
Q2 2018 Jul 10, 2018	BUY	$32.98 - $35.16 $101,875 - $108,609	3,089 Added 3.04%	104,692 $0
Q1 2018 Apr 24, 2018	SELL	$31.91 - $37.02 $182,908 - $212,198	-5,732 Reduced 5.34%	101,603 $3.61 Million
Q4 2017 Jan 19, 2018	BUY	$33.26 - $35.29 $21,153 - $22,444	636 Added 0.6%	107,335 $0
Q3 2017 Oct 10, 2017	BUY	$31.0 - $34.15 $3.31 Million - $3.64 Million	106,699	106,699 $3.81 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.

Account

Hollencrest Capital Management Pfizer Inc Transaction History